Exelixis
EXEL
#1655
Rank
C$18.44 B
Marketcap
C$73.39
Share price
0.58%
Change (1 day)
23.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: C$76.02 CAD on 2026-06-11

Lowest end of day price: C$1.83 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 17.16%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
C$337.19 2.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$35.30-0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$493.65 0.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$58.94-0.72%๐Ÿ‡ซ๐Ÿ‡ท France
C$168.68 2.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$79.06 1.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$73.71 2.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.53-13.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.31 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA